Novo Nordisk sales share by region 2023
Danish biopharmaceutical company Novo Nordisk generated almost 60 percent of its total sales in 2023 in the North American region. That was a significant seven percent increase compared to the year before. As a consequence of that, the other regional markets lost two to three percent.
